Learn more about
3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg
Watch doctors share their experiences
Watch Dr. Stuart Fox and other doctors talk about their patients’ experiences with 3-times-a-week COPAXONE®
40 mg.
Doctors have been
compensated by Teva Neuroscience, Inc.
Some have specifically said they enjoy
the fact that if they go away for a weekend, they don’t need to take
medication with them.
Injections must be at least 48 hours apart.
—Stuart Fox, MD
Take control with a proven therapy
3-times-a-week COPAXONE® 40 mg is the #1
prescribed therapy for relapsing MS in the US1*
•
Proven effective in the largest pivotal trial ever
conducted for COPAXONE®2
•
A demonstrated safety and tolerability
profile in the pivotal trial, with side effects usually mild in intensity2
•
Full access to Teva’s Shared Solutions®
network of personalized caring support
If you’re considering Teva’s COPAXONE®, making an
informed therapy decision begins by having an honest discussion with your
doctor. Use our Decision
Brochure to talk to your doctor about Teva’s COPAXONE®.
COPAXONE Co-pay Solutions®
Through COPAXONE Co-pay Solutions®, if eligible,
your co-pay for 3-times-a-week COPAXONE® 40 mg could be lowered
to $0 per month out
of pocket.†
Terms and conditions apply.
COPAXONE®
is indicated for the treatment of patients with relapsing forms of multiple
sclerosis.
Important Safety Information
Do
not take COPAXONE® if you are allergic to glatiramer acetate or
mannitol.
Some
patients report a short-term reaction right after injecting COPAXONE®.
This reaction can involve flushing (feeling of warmth and/or redness),
chest tightness or pain with heart palpitations, anxiety, and trouble
breathing. These symptoms generally appear within minutes of an injection,
last about 15 minutes, and do not require specific treatment. During the
postmarketing period, there have been reports of patients with similar
symptoms who received emergency medical care. If symptoms become
severe, call the emergency phone number in your area. Call
your doctor right away if you develop hives, skin rash with irritation,
dizziness, sweating, chest pain, trouble breathing, or severe pain at the
injection site. If any of the above occurs, do not give yourself any more
injections until your doctor tells you to begin again.
Chest
pain may occur either as part of the immediate postinjection reaction or on
its own. This pain should only last a few minutes. You may experience more
than one such episode, usually beginning at least one month after starting
treatment. Tell your doctor if you experience chest pain that lasts for a
long time or feels very intense.
A
permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at
the injection site may occur, due to local destruction of fat tissue. Be
sure to follow proper injection technique and inform your doctor of any
skin changes.
The
most common side effects in studies of COPAXONE® are redness,
pain, swelling, itching, or a lump at the site of injection, flushing,
rash, shortness of breath, and chest pain. These are not all of the
possible side effects of COPAXONE®. For a complete list, ask
your doctor or pharmacist. Tell your doctor about any side effects you have
while taking COPAXONE®.
You
are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch
*Based on total number of prescriptions for relapsing forms
of MS (IMS Health National Prescription Audit, July 2015). All Rights Reserved
by IMS.
†Applies only to
3-times-a-week COPAXONE® 40 mg. Certain limits and restrictions
apply. Terms and
Conditions: COPAXONE Co-pay Solutions® is
open to both new and existing patients who are residents of the US or
Puerto Rico and who have commercial prescription insurance coverage for
COPAXONE® 40 mg. The offer is not valid for uninsured patients
or patients covered in whole or in part by Medicaid, Medicare, TRICARE, or
any other federal or state government pharmaceutical assistance plan or
program (regardless of whether a specific prescription is covered), or by
private health benefit programs that reimburse for the entire cost of
prescription drugs. Use of this offer must be consistent with the terms of
any drug benefit provided by a health insurer, health plan, or private
third-party payor. This offer is void where prohibited by law, taxed, or
restricted. No additional purchase is required. This offer is valid only at
participating pharmacies and may be changed or discontinued at any time
without notice. This program is not health insurance.
References: 1. IMS Health National Prescription Audit,
July 2015. Data proprietary to IMS Health. 2. COPAXONE® (glatiramer
acetate injection) prescribing information. Rev. 1/2014. Teva Neuroscience,
Inc
